Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth J Betts

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|October 31, 2006
Regulating the immune response to tumoursGareth J Betts, Sarah L Clarke, Hannah E Richards, et al.
Plos One|November 7, 2013
Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in miceKristin L Griffiths, Elena Stylianou, Hazel C Poyntz, et al.
Transplantation|January 25, 2017
CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of SuppressionRebeca Arroyo Hornero, Gareth J Betts, Birgit Sawitzki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?Baalasubramanian Sivasankar, M Paula Longhi, Kathleen M E Gallagher, et al.
Journal of the National Cancer Institute|February 12, 2015
Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancerMartin J Scurr, Clare M Brown, Diana F Costa Bento, et al.
Cancer Research|December 16, 2010
Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumorsJames P Hindley, Cristina Ferreira, Emma Jones, et al.
Plos One|January 6, 2007
CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancerSarah L Clarke, Gareth J Betts, Andrea Plant, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|October 31, 2006
Regulating the immune response to tumoursGareth J Betts, Sarah L Clarke, Hannah E Richards, et al.
Plos One|November 7, 2013
Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in miceKristin L Griffiths, Elena Stylianou, Hazel C Poyntz, et al.
Transplantation|January 25, 2017
CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of SuppressionRebeca Arroyo Hornero, Gareth J Betts, Birgit Sawitzki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?Baalasubramanian Sivasankar, M Paula Longhi, Kathleen M E Gallagher, et al.
Journal of the National Cancer Institute|February 12, 2015
Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancerMartin J Scurr, Clare M Brown, Diana F Costa Bento, et al.
Cancer Research|December 16, 2010
Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumorsJames P Hindley, Cristina Ferreira, Emma Jones, et al.
Plos One|January 6, 2007
CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancerSarah L Clarke, Gareth J Betts, Andrea Plant, et al.
Pageof 1